Table I.
Inflammatory cell infiltration in the invasive front of tumor | Inflammatory cell infiltration in the center of tumor mass | ||||
---|---|---|---|---|---|
Variables | N 160 | R | P-value | R | P-value |
Age | |||||
<60 | 40 | NS | NS | NS | NS |
>60 | 120 | ||||
Gender | |||||
Female | 64 | -0.197 | 0.018 | NS | NS |
Male | 96 | ||||
Localization | |||||
Right-side | 20 | NS | NS | NS | NS |
Transverse | 14 | ||||
Left-side | 15 | ||||
Sigmoid | 29 | ||||
Rectum | 82 | ||||
Tumor growth | |||||
Expanding | 133 | NS | NS | NS | NS |
Infiltrate | 27 | ||||
Tumor size, cm | |||||
<2.5 | 27 | NS | NS | NS | NS |
2.5–5.0 | 106 | ||||
>5.0 | 27 | ||||
TNM stage | |||||
1 | 42 | NS | NS | -0.200 | 0.012 |
2 | 31 | ||||
3 | 69 | ||||
4 | 18 | ||||
Duke stage | |||||
A | 39 | NS | NS | -0.218 | 0.009 |
B | 35 | ||||
C | 69 | ||||
D | 17 | ||||
Adenocarcinoma type | |||||
Partim muc | 30 | NS | NS | NS | NS |
Nonmuc | 130 | ||||
Percentage of mucinous component | |||||
10–30% | 15 | NS | NS | NS | NS |
30–50% | 15 | ||||
Grade of malignancies | |||||
2 | 148 | NS | NS | NS | NS |
3 | 12 | ||||
Preoperative treatment | |||||
Yes | 53 | NS | NS | NS | NS |
No | 107 | ||||
Treatment response | |||||
SD | 26 | NS | NS | NS | NS |
PR | 27 | ||||
pT stage | |||||
1 | 3 | NS | NS | -0.175 | 0.036 |
2 | 62 | ||||
3 | 91 | ||||
4 | 4 |
Bold numbers indicate values considered to be statistically significant. Spearman's correlation coefficient test; NS, not statistically significant.